IP Library Granted Patent US 7,973,157
Granted Patent B2
US 7,973,157 · App. 11/450,978 · Granted Jul 5, 2011

Imino and amino sugar purification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,973,157
App. No.
11/450,978
Granted
Jul 5, 2011
Kind
B2
Abstract

Novel processes for the purification of an imino or amino sugar, such as D-1-deoxygalactonojirimycin (DGJ). Particularly, there are described processes for the purification of multi-kilogram scale sugars using hydrochloric acid.

Claims (29)

1. A method for the purification of a crude D-1-deoxygalactonojirimycin contaminated with an alkali- or alkali earth metal-containing compound comprising:

(a) admixing

D-1-deoxygalactonojirimycin with a solution having at least 35% hydrochloric acid or with hydrogen chloride gas to saturation to form a chloride salt of the alkali- or alkali earth metal-containing compound;

(b) forming the chloride salt of the alkali- or alkali earth metal-containing compound;

(c) removing the chloride salt of the alkali- or alkali earth metal-containing compound wherein the chloride salt is a solid; and

(d) crystallizing D-1-deoxygalactonojirimycin by addition of a solvent miscible with hydrochloric acid.

2. The method of claim 1 , wherein D-1-deoxygalactonojirimycin is mixed with water and then saturated with hydrogen chloride gas.

3. The method of claim 1 , wherein D-1-deoxygalactonojirimycin is mixed with a solution having at least 35% hydrochloric acid.

4. The method of claim 1 , wherein the alkali- or alkali earth metal-containing compound was formed from the addition of sodium methoxide.

5. The method of claim 1 , wherein crystallizing D-1-deoxygalactonojirimycin comprises adding a water/ethanol solvent mixture.

6. The method of claim 1 , wherein the amount of metal-containing compound is reduced to less than 0.01% by weight following step (d).

7. The method of claim 1 , wherein D-1-deoxygalactonojirimycin is at least 98% pure following step (d).

8. The method of claim 1 , wherein D-1-deoxygalactonojirimycin is at least 99% pure following step (d).

9. The method of claim 1 , wherein at least 5 kg of D-1-deoxygalactonojirimycin is produced following purification.

10. The method of claim 1 , further comprising synthesizing D-1-deoxygalactonojirimycin from a sugar starting material.

11. A method for purification of a crude D-1-deoxygalactonojirimycin or the HCl salt thereof contaminated with an alkali- or alkali earth metal-containing compound comprising:

(a) admixing the crude D-1-deoxygalactonojirimycin or the HCl salt thereof with a solution having at least 35% hydrochloric acid or with hydrochloric gas to saturation to form a chloride salt of the alkali- or alkali earth metal-containing compound;

(b) forming the chloride salt of the alkali- or alkali earth metal-containing compound;

(c) removing the chloride salt of the alkali- or alkali earth metal-containing compound; and

(d) crystallizing D-1-deoxygalactonojirimycin.HCl.

12. The method of claim 11 , wherein crystallizing D-1-deoxygalactonojirimycin.HCl comprises adding a water/ethanol solvent mixture.

13. The method of claim 11 , wherein D-1-deoxygalactonojirimycin.HCl is at least 98% pure following step (d).

14. The method of claim 11 , wherein D-1-deoxygalactonojirimycin.HCl is at least 99% pure following step (d).

15. The method of claim 11 , further comprising synthesizing D-1-deoxygalactonojirimycin.HCl from a sugar starting material.

16. The method of claim 15 , where the sugar starting material is a galactose.

17. The method of claim 1 , further comprising removing the chloride salt of the alkali- or alkali earth metal-containing compound by filtration.

18. The method of claim 11 , further comprising removing the chloride salt of the alkali- or alkali earth metal-containing compound by filtration.

19. The method of claim 1 , wherein the crude D-1-deoxygalactonojirimycin is a 5-amino-5-deoxy-D-galactopyranose derivative of the form:

20. The method of claim 11 , wherein the D-1-deoxygalactonojirimycin or the HCl salt thereof is admixed with a solution having at least 35% HCl.

Assignments (9)
SECURITY INTEREST Recorded Oct 6, 2023
From: AMICUS THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 065177/0196 →
RELEASE OF SECURITY INTEREST Recorded Oct 6, 2023
From: HAYFIN SERVICES LLP
To: AMICUS THERAPEUTICS, INC.
Reel/Frame 065164/0945 →
SECURITY INTEREST Recorded Jul 30, 2020
From: AMICUS THERAPEUTICS, INC.
To: HAYFIN SERVICES LLP, AS AGENT
Reel/Frame 053365/0342 →
RELEASE OF SECURITY INTEREST Recorded Jul 30, 2020
From: BPCR LIMITED PARTNERSHIP
To: AMICUS THERAPEUTICS, INC.
Reel/Frame 053360/0659 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
SECURITY INTEREST Recorded May 11, 2020
From: AMICUS THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052625/0916 →
SECURITY INTEREST Recorded Sep 28, 2018
From: AMICUS THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 047004/0208 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME FROM "PETERSON, ROBERT" TO "PETERSEN, ROBERT" PREVIOUSLY RECORDED ON REEL 018197 FRAME 0783. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF ASSIGNOR NAME. Recorded Sep 13, 2006
From: MAJOR, MICHAEL; PETERSEN, ROBERT; KOSINSKI, SZYMON
To: AMICUS THERAPEUTICS, INC.
Reel/Frame 018241/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2006
From: MAJOR, MICHAEL; PETERSON, ROBERT; KOSINSKI, SZYMON
To: AMICUS THERAPEUTICS, INC.
Reel/Frame 018197/0783 →